Safety aspects of probiotic bacterial strains Lactobacillus rhamnosus HN001 and Bifidobacterium animalis subsp. lactis HN019 in human infants aged 0-2 years

International Dairy Journal

Volumn 19, Issue 3, 2009, Pages 149-154

  Dekker, James W ^a   Wickens, Kristin ^b   Black, Peter N ^c   Stanley, Thorsten V ^b   Mitchell, Edwin A ^c   Fitzharris, Penny ^d   Tannock, Gerald W ^e   Purdie, Gordon ^b   Crane, Julian ^b  

^a FONTERRA RESEARCH CENTRE   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d AUCKLAND CITY HOSPITAL   (New Zealand)

^e UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EVENTS; BACTERIAL STRAINS; BIFIDOBACTERIUM; BREASTFEEDING; CLINICAL TRIALS; HUMAN INFANTS; IMMUNE SYSTEMS; LACTOBACILLUS RHAMNOSUS; NORMAL GROWTHS; PROBIOTIC; PROBIOTIC STRAINS; PROBIOTICS; SAFETY ASPECTS; TREATMENT GROUPS;

POPULATION STATISTICS;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS; LACTOBACILLUS RHAMNOSUS;

EID: 57549098999     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2008.10.004     Document Type: Article

References (33)

1. Ahmed M., Prasad J., Gill H., Stevenson L., and Gopal P. Impact of consumption of different levels of Bifidobacterium Lactis HN019 on the intestinal microflora of elderly human subjects. Journal of Nutrition, Health and Aging 11 (2007) 26-31
2. Arunachalam K., Gill H.S., and Chandra R.K. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). European Journal of Clinical Nutrition 54 (2000) 263-267
3. Asher M.I., Keil U., Anderson H.R., Beasley R., Crane J., Martinez F., Mitchell E.A., Pearce N., Sibbald B., Stewart A.W., et al. International study of asthma and allergies in childhood (ISAAC): rationale and methods. European Respiratory Journal 8 (1995) 483-491
4. Chiang B.L., Sheih Y.H., Wang L.H., Liao C.K., and Gill H.S. Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses. European Journal of Clinical Nutrition 54 (2000) 849-855
5. Dekker J., Collett M., Prasad J., and Gopal P. Functionality of probiotics - potential for product development. Forum of Nutrition 60 (2007) 196-208
6. FAO/WHO. Joint FAO/WHO working group report on drafting guidelines for the evaluation of probiotics in food (2002), Joint Food and Agriculture Organization of the United Nations and World Health Organization Working Group, London Ontario, Canada p. 11
7. Favier C.F., Vaughan E.E., De Vos W.M., and Akkermans A.D.L. Molecular monitoring of succession of bacterial communities in human neonates. Applied and Environmental Microbiology 68 (2002) 219-226
8. Gill H.S., and Rutherfurd K.J. Immune enhancement conferred by oral delivery of Lactobacillus rhamnosus HN001 in different milk-based substrates. Journal of Dairy Research 68 (2001) 611-616
9. Gill H.S., and Rutherfurd K.J. Probiotic supplementation to enhance natural immunity in the elderly: effects of a newly characterized immunostimulatory strain Lactobacillus rhamnosus HN001 (DR20(TM)) on leucocyte phagocytosis. Nutrition Research 21 (2001) 183-189
10. Gill H.S., Rutherfurd K.J., and Cross M.L. Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. Journal of Clinical Immunology 21 (2001) 264-271
11. Gill H.S., Rutherfurd K.J., Cross M.L., and Gopal P.K. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. American Journal of Clinical Nutrition 74 (2001) 833-839
12. Gopal P., Dekker J., Prasad J., Pillidge C., Delabre M., and Collett M. Development and commercialisation of Fonterra's probiotic strains. Australian Journal of Dairy Technology 60 (2005) 174-183
13. Gopal P.K., Prasad J., and Gill H.S. Effects of the consumption of Bifidobacterium lactis HN019 (DR10TM) and galacto-oligosaccharides on the microflora of the gastrointestinal tract in human subjects. Nutrition Research 23 (2003) 1313-1328
14. Gueimonde M., Laitinen K., Salminen S., and Isolauri E. Breast milk: a source of bifidobacteria for infant gut development and maturation?. Neonatology 92 (2007) 64-66
15. Heilig H.G.H.J., Zoetendal E.G., Vaughan E.E., Marteau P., Akkermans A.D.L., and de Vos W.M. Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Applied and Environmental Microbiology 68 (2002) 114-123
16. Hoyos A.B. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. International Journal of Infectious Diseases 3 (1999) 197-202
17. Hung-Chih L., Bai-Horng S., An-Chyi C., Tsung-Wen L., Chang-Hai T., Tsu-Fuh Y., and Oh W. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 115 4 (2005) 1
18. Kalliomaki M., Salminen S., Arvilommi H., Kero P., Koskinen P., and Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357 (2001) 1076-1079
19. Kopp M.V., Hennemuth I., Heinzmann A., and Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 121 (2008) e850-e856
20. Martin R., Heilig G.H.J., Zoetendal E.G., Smidt H., and Rodriguez J.M. Diversity of the Lactobacillus group in breast milk and vagina of healthy women and potential role in the colonization of the infant gut. Journal of Applied Microbiology 103 (2007) 2638-2644
21. Parracho H., McCartney A.L., and Gibson G.R. Probiotics and prebiotics in infant nutrition. Proceedings of the Nutrition Society 66 (2007) 405-411
22. Penders J., Thijs C., Vink C., Stelma F.F., Snijders B., Kummeling I., van den Brandt P.A., and Stobberingh E.E. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118 (2006) 511-521
23. Prasad J., Gill H.S., Smart J., and Gopal P.K. Selection and characterisation of Lactobacillus and Bifidobacterium strains for use as probiotics. International Dairy Journal 8 (1998) 993-1002
24. Sanders M.E. Summary of probiotic activities of Bifidobacterium lactis HN019. Journal of Clinical Gastroenterology 40 (2006) 776-783
25. Tapiainen T., Ylitalo S., Eerola E., and Uhari M. Dynamics of gut colonization and source of intestinal flora in healthy newborn infants. APMIS 114 (2006) 812-817
26. Taylor A.L., Dunstan J.A., and Prescott S.L. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology 119 (2007) 184-191
27. WHO. The use and interpretation of anthropometry and physical status: the use and interpretation of anthropometry (1995), WHO Expert Committee on Physical Status, Geneva, Switzerland
28. Wickens K., Black P.N., Stanley T.V., Mitchell E., Fitzharris P., Tannock G.W., Purdie G., and Crane J. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. Journal of Allergy and Clinical Immunology 122 (2008) 788-794
29. Zhou J.S., and Gill H.S. Immunostimulatory probiotic Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 do not induce pathological inflammation in mouse model of experimental autoimmune thyroiditis. International Journal of Food Microbiology 103 (2005) 97-104
30. Zhou J.S., Gopal P.K., and Gill H.S. Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro. International Journal of Food Microbiology 63 (2001) 81-90
31. Zhou J.S., Rutherfurd K.J., and Gill H.S. Inability of probiotic bacterial strains Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 to induce human platelet aggregation in vitro. Journal of Food Protection 68 (2005) 2459-2464
32. Zhou J.S., Shu Q., Rutherfurd K.J., Prasad J., Birtles M.J., Gopal P.K., and Gill H.S. Safety assessment of potential probiotic lactic acid bacterial strains Lactobacillus rhamnosus HN001, Lb. acidophilus HN017, and Bifidobacterium lactis HN019 in BALB/c mice. International Journal of Food Microbiology 56 (2000) 87-96
33. Zhou J.S., Shu Q., Rutherfurd K.J., Prasad J., Gopal P.K., and Gill H.S. Acute oral toxicity and bacterial translocation studies on potentially probiotic strains of lactic acid bacteria. Food and Chemical Toxicology 38 (2000) 153-161